Marine Derived Drugs Market Scope And Analysis

  • Report Code : TIPRE00023145
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Marine-derived Drugs Market Analysis and Share - 2031

Buy Now

Marine-derived Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 8.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Phenol
  • Steroid
  • Ether
  • Peptide
  • Other
By Source
  • Algae
  • Invertebrates
  • Microorganisms
By Mode of Delivery
  • Anti-microbial
  • Anti-tumor
  • Anti-cardiovascular
  • Anti-viral
  • Anti-inflammatory
  • Others
By End Users
  • Hospital and Clinics
  • Pharmacy
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc
  • Abbott
  • GlaxoSmithKline PLC
  • Aker BioMarine AS
  • Pharma Mar S A
  • Eisai Co Ltd
  • Aker BioMarine AS
  • Sea Run Holdings Inc
  • Aphios Corporation